![Page 1: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/1.jpg)
QIA Presentations
1Dr Luke Kane and Hasiba Stanakzai
2 Selena Yan
3 Dr Dimple Shah and Dimple Varsani
4 Dr Sarah Thurgood
5 Shreena Patel
6 Dr Diana Davenport and Nada Imame
7Dr Kara Sheehan and Dr Pratiksha Nirmal
8Dr Charles Wharton and
Vivek Patel
9 George Black
10 Mery Ayele
![Page 2: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/2.jpg)
Participant Feedback
![Page 3: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/3.jpg)
What was the best part of the placement programme and why?
“Participating at a CCG meeting which the GP had with the CCG pharmacist…. gave me a broader perspective of the work between local commissioning body and primary care.”
Pre-reg pharmacist
“Being able to observe the different members of the GP practice and knowing everyone's role.”
Pre-reg pharmacist
“Understanding the workings of the GP practice”
Pharmacist tutor
Participant Feedback
![Page 4: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/4.jpg)
What was the best part of the placement programme and why?
“Spending time with the local pharmacy and getting a detailed insight into the workings of a community pharmacy, the services they provide and how we can work to improve relations.”
GP Trainee
“Pharmacist trainee gained understanding of prescribing dilemmas in primary care, especially with complex patients”
GP Trainer
Participant Feedback
![Page 5: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/5.jpg)
“This is clearly a fantastic project….My colleague had her
previous registrar take part more than a year ago and found it
greatly beneficial, helping GPs to understand the processes of
community pharmacists and the training process
trainee pharmacists go through. ”
GP Trainer, HEE NCEL
Participant Feedback
![Page 6: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/6.jpg)
Objective:
“To develop inter-professional learning between
CP and GP trainees and instil a culture of inter-professional
learning and a multidisciplinary approach to practice that
reduces profession based silo working”
![Page 7: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/7.jpg)
![Page 8: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/8.jpg)
•
•
•
•
•
•
•
![Page 9: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/9.jpg)
•
•
•
•
•
•
•
![Page 10: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/10.jpg)
•
•
•
•
•
•
![Page 11: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/11.jpg)
•
•
•
![Page 12: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/12.jpg)
•
•
•
•
•
•
•
•
•
•
•
![Page 13: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/13.jpg)
![Page 14: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/14.jpg)
Quality Improvement Auditproject (QIA)PRESCRIPTION OPTIMISATION OF ORAL CONTRACEPTIVE AND ANTI-HYPERTENTIVES
SELEN A YA N
DR L I CHUN LOW
![Page 15: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/15.jpg)
IntroductionMedicines Optimisation, the Carter Report and the Five Year Forward View
◦ Make medicines optimisation part of routine practice
◦ Take every opportunity to identify areas to improve efficiency within the NHS
◦ “Helping patients get the right care, at the right time, in the right place.Making more appropriate use of primary care, ... and community pharmacies, as well as the 379 urgent care centres throughout the country.”
Issues identified at Practice
◦ Large amount of patients attending GP appointments for simple reviews for Oral Contraceptive repeat prescriptions
◦ Pharmacy repeat orders for these medications regularly rejected as patients are due for a review (e.g. blood pressure check)
◦ Creates unnecessary administrative work and wastes time; an inefficient system
![Page 16: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/16.jpg)
Proposed Plan Utilise monitoring services already provided by local pharmacies ◦ Blood Pressure◦ Weight and Height◦ Identification of side effects and danger signs for referral
Expand these services to include stable patients on Oral Contraceptives (at 3 months after starting and annually)
◦ Shift regular monitoring work to pharmacies and refer back to GP if issues arise
◦ Significantly reduces administrative work◦ Tighten the relationship between the surgery and the pharmacy◦ Improves efficiency and patient satisfaction
![Page 17: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/17.jpg)
![Page 18: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/18.jpg)
Implementation
![Page 19: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/19.jpg)
Note to pharmacistTemplate
![Page 20: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/20.jpg)
So…HOW DOES IT IMPROVE OUR PERFORMANCE?
![Page 21: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/21.jpg)
Patient’s point of view•Free
•Non-appointment based
•Closer to home, convenient, especially for those who at work/ reduced mobility
•Reduce white coat effect
•INCREASE ADHERENCE
![Page 22: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/22.jpg)
Pharmacy’s point of view•Low cost
•Established service
•Simple training
•Reduced rejected item due to ‘BP check’
•Reduced workload of chase up
•Increase potential customer
•Increase opportunity of MUR/ NMS
![Page 23: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/23.jpg)
Surgery’s point of view•Effectively use for the appointment slot
•Frees up GP times • Patients with more complicated case
• Emergency slot
• Double slot
•QOF target
![Page 24: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/24.jpg)
Conclusion
◦ Win-win situation◦ ↓ workload of both surgery and pharmacy
◦ Maximise patient’s convenience
◦ Further expand the clinical role of the service◦ Assessment on risk, ADRs and DDI
◦ Free up GP’s time into more complicated cases
![Page 25: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/25.jpg)
SHARING
THE LOAD
DIMPLE SHAH AND DIMPLE VARSANI
LONDON AND THE SOUTH EAST TRAINEE GP AND
TRAINEE PHARMACIST PAIRING PROJECT, 2017
![Page 26: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/26.jpg)
AIMS
Share resources
Improve communication
Efficient
Cost-effective
Potentially reduce consultations for medication reviews at
the GP surgery
In line with the GP 5 Year Forward View
![Page 27: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/27.jpg)
MEDICATION REVIEWS
GP
• Every 6 months approximately
PHARMACY
• Every year
• £28 per MUR consultation
• Capped at 400 per year
• 70% targeted
• Targeted:
• Recently discharged
• High risk medications
• Cardiovascular disease
• Other long term conditions e.g. respiratory disease
![Page 28: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/28.jpg)
![Page 29: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/29.jpg)
WHAT DOES AN MUR
INVOLVE?
Patient’s medication
Time
Compliance
Other health
concerns
Side effects
Health promotion
opportunities
Patient’sunderstanding
Usage (technique)
![Page 30: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/30.jpg)
WHAT DOES A MEDICATION
REVIEW INVOLVE?
![Page 31: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/31.jpg)
WHAT DOES A MEDICATION
REVIEW INVOLVE?
Patient factors:Any concerns/problems?
Non-adherence?
Compliance aid needed?
Clinical need:Does the patient know why they
are taking it?
Do they still need it?
Is it working?
Appropriateness:Any high risk medications?
Any drug interactions?
Right quantities?
Monitoring:Do they need any monitoring?
![Page 32: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/32.jpg)
Does this seem
similar to you?
![Page 33: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/33.jpg)
WHAT WE HAVE PILOTED
• List of all patients at our surgery who have nominated the
pharmacy
• Exclusions: patients who are extremely complicated and known to both
parties, patients not on any regular medications
• Pilot of 10 patients
• MUR completed at Jade pharmacy, along with BP check if relevant
• Email via nhs.net encrypted email to practice email address
![Page 34: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/34.jpg)
WHAT WE HAVE PILOTED
• Triaged like all other letters to the relevant clinician
• Uploaded to medical notes
• If clinician satisfied that this is sufficient for a medication review then can adjust the me review date
• Patient offered option of requesting med r/v with a GP
• Clinician’s responsibility to check if they need any monitoring or additional tests
![Page 35: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/35.jpg)
SUGGESTED FLOW OF EVENTS
Medication Review due
Patient TCI Pharmacy
Agree sharing/ Consent
Pharmacy MUR+BP Checked
Email To EHMC
Send to Clinician
Coded into the notes + any action
Patient Housebound/
deliveryReview in GP
Not suitable for pharmacy R/V
Review in GP
Review in GP
![Page 36: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/36.jpg)
EXAMPLE
All identifiable details have been deleted
![Page 37: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/37.jpg)
![Page 38: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/38.jpg)
![Page 39: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/39.jpg)
EXAMPLE CONT.
• Data uploaded to EMIS
• Code into PMR – patient advised re exercise, patient advised re
diet
• Clinical assessment- further need for blood tests e.g.
lipids/HbA1c
• Medication review date to adjust- If bloods in date, and no
issues identified
Therefore: saves 1 appointment with the GP, and contributes
towards the MUR target for the pharmacy (£28 per MUR)
![Page 40: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/40.jpg)
NEXT STEPS …
• Take this to the practice meeting with a view to sharing with
the rest of the GPs and the pharmacy
• Can we improve it? What else could we do?
• Extend the study to the rest of the patients on the Jade
pharmacy list (approx 110)
• Extend to other local pharmacies
![Page 41: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/41.jpg)
REFERENCES
Health and Social Care Board. Medication Review Guidance.
2016 [accessed via
http://www.medicinesgovernance.hscni.net/download/primar
ycare/Guidelines/HSCB-Primary-Care-Medication-Review-
Guidance-May-2016.pdf July 2017]
http://psnc.org.uk/services-commissioning/advanced-
services/murs/national-target-groups-for-murs/ [accessed
July 2017]
![Page 42: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/42.jpg)
HEE LaSE Trainee
Pharmacist and GP Project
– Asthma Management in
Community Pharmacies
Sarah Thurgood and Barinder Kaur
![Page 43: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/43.jpg)
Background HEE LaSE collaborative working project between GP
registrars and community pre-registration pharmacists
Joint quality improvement project
Increase dialogue and understanding between
Community Pharmacy and General Practice Surgeries
Better understand how the practice functions, and how
pharmacists can aid many of these functions
![Page 44: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/44.jpg)
Choice of Project Discussed at practice meeting and applied SMART
principles to ideas
Specific- An area which needs improvement needs to be identified
Measurable- By May 31st the new procedure will be implemented and the data required for the completion of the project will be collected.
Achievable – We need to make sure that we will be able to accomplish the goals for this project
Relevant – The outcome of this identified need should be able to be continued in the future.
Time-bound- – In order to achieve this goal, there will be timeframes for when each task needs to be completed.
![Page 45: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/45.jpg)
Choice of Project Keen to explore clinical monitoring area
Ruled out monitoring requiring phlebotomy due to practical constraints at the surgery and time constraints of the project
Identified national area of need and confirmed need within practice
Identified area for which pharmacist will receive additional benefit
Identified area with potential benefit to local secondary care services
Identified area of benefit to patients – both with potential for improved clinical care and access to services.
![Page 46: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/46.jpg)
Method - Template Review template designed in line with British Thoracic
Society guidelines and Royal College of Physicians ‘3 questions’ approach:
Have you had difficulty sleeping because of your asthma symptoms (including cough)?
Have you had your usual asthma symptoms during the day (cough, wheeze, chest tightness or breathlessness)?
Has your asthma interfered with your usual activities (e.g. housework, work/school etc)?
Entered onto template in same format as QoF on Vision
![Page 47: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/47.jpg)
Method - Template Lifestyle interventions: trigger identification and avoidance,
exercise advice
Medication review: prescribed and OTC which can exacerbate asthma
Smoking cessation: offered in-pharmacy counselling or referral to stop smoking service
Inhaler technique: reviewed and demonstrated
Blood pressure check
Advice for further action e.g. attend for GP review if using SABA >3x/week
Patient preference for review
![Page 48: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/48.jpg)
Method Vision used to produce list of patient with outstanding
asthma annual reviews
Joint users of Practice and Pharmacy contacted first, then
extended to remainder of list
Contacted by telephone and offered review by community
pharmacist either in the practice or at the pharmacy
Encouraged to attend in person but offered telephone review
if declined
Appointment given and patients asked to bring inhalers
![Page 49: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/49.jpg)
Results 41 joint users identified – 5 successfully contacted
Total of 120 patients telephoned.
21 patients successfully contacted
20 agreed to review, 1 declined
14 reviews by telephone, 6 in person
6 offered smoking cessation services, 1 accepted
![Page 50: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/50.jpg)
Results No patients had a written asthma plan
Patients identified as having poor asthma control as per
RCP 3 questions advised to see own GP within 2 weeks
One patient identified as not using medication as prescribed,
therefore using excess SABA, advised to use steroid
inhalers as instructed
One patient advised to use spacer device due to poor
inhaler technique
All patients preferred option of pharmacy-based assessment
![Page 51: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/51.jpg)
Discussion and limitations Small sample size
Difficulty contacting patients – time scale of project
May need multiple attempts / calling at different times
of day / written contact if unsuccessful
Co-ordination of lists – data sharing
![Page 52: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/52.jpg)
Potential advantages: GPs Ease primary care workload
The majority of GPs describe their workload as excessive (84%)
Between 2008/09 and 2013/14, the number of GP consultations in England rose by 19%
Number of headcount GPs in the UK only rose by 4.1%
One in eight GP practice nurse positions are vacant(BMI/Health and Social Care Information Centre)
Meet QoF targets for asthma reviews
Free up nursing and GP time for other patient needs – 11.5hrs
Closer relationship with local pharmacies
Access to Pharmacy Integration Funds
![Page 53: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/53.jpg)
Potential advantages for
pharmacy Encourage loyalty from patients
Encourage patient perception of pharmacists’ role in
clinical management, encouraging presentation for
minor ailments etc
Included in the New Medicines Service (NMS) and as
part of a Medicines Use Review (MUR)
Improved relationship with local GP practices including
awareness of prescribing practices and increasing
accessibility for queries etc.
![Page 54: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/54.jpg)
Potential advantages for
secondary care Relieve secondary care pressures of A&E attendances and
admissions
Asthma attacks hospitalise someone every 8 minutes
185 people are admitted to hospital because of asthma attacks every day in the UK
Patient education is key in managing asthma symptoms, by spending time during a review to educate the patient on the use of their inhaler and making sure they are adherent in the use of their medication, we could prevent admissions into hospital
(PSNC / www.england.nhs.uk)
![Page 55: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/55.jpg)
Potential advantages for
patients Improved asthma management
39% of patients using more that 12 SABA annually with no annual review –higher mortality risk
(PSNC/NRAD)
Improved access
Choice of times
Choice of site
Walk-in service
Parking issues!
Avoids duplication of reviews
Addresses medication wastage – improving NHS budgets for other areas of care
Improved access to GP / PN for other issues
![Page 56: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/56.jpg)
Moving forward… Identified learning need for the practice regarding
written asthma plans – we will address this at a
forthcoming practice meeting
Roll out of project to other local pharmacies – contact
them directly to discuss project
Roll out to other DGC practices – include in CCG
bulletin or present at PLT
To infinity and beyond…
![Page 57: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/57.jpg)
References https://www.lasepharmacy.hee.nhs.uk/primary-care/trainees-in-general-practice/
BMA Survey of GPs in England Oct-Nov 2016
Health and Social Care Information Centre (2015) General and Personal Medical Services , England - 2004- 2014, As at 30 September
PSNC Main site. (2017). Essential facts, stats and quotes relating to asthma
NRAD: Why asthma still kills: National Review of Asthma Deaths May 2014
British Thoracic Society Guidelines for Management of Asthma in Adults
Pearson MG, CE B, editors. Measuring clinical outcome in asthma: a patient-focused approach London: Royal College of Physicians; 1999
www.england.nhs.uk National NHS campaign urges people to stay well this winter
![Page 58: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/58.jpg)
![Page 59: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/59.jpg)
Quality
Improvement
Audit
By Shreena and Heloise
![Page 60: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/60.jpg)
What is the problem?
– There are many things that could be improved
between community pharmacies and GP surgeries,
however the major issue which requires immediate
attention involves the communication barrier
between the two when a medicine is unavailable
from suppliers or is discontinued
![Page 61: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/61.jpg)
What we did our Quality
Improvement Audit on
– As our placements were over a one month period, we
decided to collate data by finding out how many patients
had a problem with their medicine prescribed by their
doctor, due to manufacturing issues or discontinuation.
– During the data collection period, we analysed each
prescription brought in by patients in addition to the
electronic scripts, and set aside those that included items
which had a manufacturing issue or were discontinued.
![Page 62: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/62.jpg)
Medicines with manufacturing
problems at the time:
– Urea 10% cream
– Sumatriptan 100mg
– Sodium Cromoglicate eye drops
– Prempak-C
– Hepatitis A vaccine
– Yacella tablets
– Emerade injection
– Sofradex eye drops
![Page 63: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/63.jpg)
Results
0
1
2
3
4
5
6
7
8
Number of patients that have experienced manufacturing problems with their medicine
![Page 64: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/64.jpg)
Evaluation
– A total of 24 patients experienced manufacturing problems
with their medication during the one month period
allocated for this audit
– Majority of the patients involved were dissatisfied with the
GP appointment system with a few stating it would take a
week or more to receive another appointment to see their
doctor
![Page 65: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/65.jpg)
Putting things into perspective
One pharmacy = 24 manufacturing problems in one month
Over a one year period
= Approximately, 288 manufacturing problems
Within a local area (approx. 10 pharmacies)
= 2880 problems with prescribed medication solely due to manufacturing issues.
![Page 66: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/66.jpg)
Finding a solution:
We implemented various communication methods in order to make
the GP's aware of the manufacturing problems with certain medicines:
– sending a weekly letter to the GP surgery
– sending an email every time there is a manufacturing problem
– call the GP directly to tell them about the issue
The most effective method we found was:
To send the GP practice an e-mail once a week through their NHS email
(so that all the doctors in the practice receive the email), using the
template, informing the doctors on which medicines have problems
![Page 67: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/67.jpg)
Sample of the template
![Page 68: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/68.jpg)
Conclusion
Although there are many problems that both GP practices and community pharmacies face on a daily basis, we believe that the issue that we chose can easily be prevented.
We believe that this would help ease the burden on GP’s by not constantly having to change the medication prescribed and it would increase patient satisfaction.
We also believe it would help pharmacists to ensure a smooth process between the patient handing in a prescription and receiving their medication.
![Page 69: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/69.jpg)
Minor ailment schemeDr Diana Davenport and Nada Imame
![Page 70: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/70.jpg)
Medical Centre and pharmacy ◦ ?mutually beneficial topic
The minor ailment scheme◦ Seemingly limited uptake of the scheme from
patients
◦ Increasing this would reduce doctor workload
◦ Financially beneficial for the pharmacies
![Page 71: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/71.jpg)
GPs- strained service, 5 year forward view, future of General practice, thinking more laterally about utilising allied health care professionals- beneficial to workload.
Reception staff- ideally placed to help inform the patients about the service◦ Issue the passports
◦ Answer queries via reception and telephones.
![Page 72: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/72.jpg)
Pharmacies- Financial incentives to provide minor ailment services.
Patients- save time waiting for a GP appointment. Free if getting free prescriptions.
Practice pharmacist- looking at expanding her role in practice to include minor ailments.
![Page 73: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/73.jpg)
To increase the uptake and awareness of the minor ailment scheme
A secondary aim was to identify what other services local pharmacies provide for easy reference at the surgery.
![Page 74: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/74.jpg)
GPs: a questionnaire was circulated:
◦ Are you aware of the minor ailment scheme? Yes/No
◦ What conditions can be dealt with using the minor
ailment scheme?
◦ How can patients access the scheme?
◦ Are you aware of any limitations to the scheme?
◦ Do you feel patients are well informed about the
scheme?
◦ How do you think we could improve uptake at the
surgery?
![Page 75: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/75.jpg)
Reception staff were interviewed with the following questions in mind:
◦ Where are the minor ailment passports kept
◦ Who can give them out
◦ When can you give them out
◦ Do you know which pharmacy’s offer the scheme?
◦ What problems do you encounter with patients?
◦ How can we improve uptake of the scheme?
◦ Do you feel sufficiently trained.
![Page 76: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/76.jpg)
local pharmacies were approached with the following questionnaire:
◦ Do you offer the minor ailment scheme?
◦ Are you a Brent or Camden pharmacy?
◦ If yes- what are the benefits for your pharmacy?
◦ If yes- how is the service provided? How to you inform patients about
it?
◦ If yes- is the scheme well taken up by patients at your practice? What
seems to be the limitations from a patient’s perspective?
◦ If yes- are there any problems with the scheme- i.e. borough issues?
Practicality issues? Burden on staff?
◦ If no- what are your concerns about implementing the scheme?
◦ If no- what would need to change in order for you to implement the
scheme?
◦ What other services do you provide?
![Page 77: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/77.jpg)
From the GPs who took part
◦ 100% were aware of the scheme.
◦ There was no definitive understanding about the
breadth that is covered by the minor ailment scheme
or where to find this information
◦ The GPS were split in their understanding how
patients get access to the scheme ?from us or ? From
the pharmacies
◦ It was unanimously felt that patients were not well
informed about the scheme
![Page 78: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/78.jpg)
From the Pharmacy’s questioned:
◦ they will only get reimbursed if the borough they are in commission the service
i.e. Camden pharmacies will do and Brent don't.
◦ Benefits they identified:
supply medication without the need for a prescription
saves time for GP surgeries
money for pharmacy (reimbursed price of medication+consultation/dispensing fee)
patients can be seen at any time; no appointment needed
◦ Limitation/problems they identified:
can only provide specific medications on the list and has to be within medication
licensing i.e cannot give chloramphenicol eye drops to under 2 years old - must see GP
all generic and some patients want brand i.e paracetamol vs calpol
Not all local pharmacies can offer the service, therefore patients may not be able to use
regular pharmacy if want to use the service
patient's not aware of what can be provided by pharmacy
![Page 79: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/79.jpg)
Thoughts from reception:
All were aware of service and where minor ailment passports kept
Most only handed out to patients when patient requested them (either already had a passport but need a new one or directed by GP)
Not given training about the scheme so unsure of what it actually was and unsure of what sort of illness it covers
There were fears about directing patients to pharmacies as a doctor may actually have preferred to see them i.e. May not have been a minor ailment and more serious
Reception don't have information about which pharmacies offer the service
![Page 80: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/80.jpg)
1) GPs not fully informed what can be offered and how we can offer this service to patients
2) Reception staff felt inadequately trained to suggest the minor ailment scheme to patients
3) No knowledge of what pharmacies do or do not offer the minor ailment service.
4) General lack of advertisement of the minor ailment service, in the practice and in pharmacies.
![Page 81: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/81.jpg)
1) Posters on electronic patient information screen in doctors waiting room.2) Posters in GP rooms- sent to GPs3) Poster put on the practice website4) For the information of our doctors and receptions we produced a list of the
local pharmacies and the other services they offer. This has been printed and is at reception for quick reference.
5) Have been able to update all staff on how patients access the service, of what is covered, and reassure them of the protocols the pharmacists follow to ensure patient safety and direct to doctors if necessary.
Ongoing changes:1) Plans to improve reception training..2) Minor ailment scheme and the baby clinic
At the pharmacy1) increase in advertisement of the scheme with poster/leaflets.2) counter staff training to educate them about what is covered within the
scheme.
![Page 82: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/82.jpg)
![Page 83: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/83.jpg)
![Page 84: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/84.jpg)
![Page 85: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/85.jpg)
One ongoing limitation to patient uptake is that the Medical Centre falls on the boundary between three boroughs◦ The majority of local pharmacies are in Brent.
◦ Brent CCG does not commission the service.
Time was a limitation◦ trying to fit some of our suggested service improvements
whilst having the backing of other staff needed to fit in with ongoing initiatives at the practice, not everything could be completed prior to this presentation.
![Page 86: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/86.jpg)
We have managed to implement interventions which should easily improve patient, doctor, reception and pharmacy awareness
There are still some ideas to implement fully
Following this we will be re-questioning the relevant parties to get formal feedback
Also will be liaising with reception teams to see if could quantitatively audit the dispensing of the minor ailment forms to formally assess success.
Initial feedback from staff has been very positive
![Page 87: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/87.jpg)
Further development of this project? ◦ how could the in practice pharmacist consult patients and
offer some minor ailment work to further alleviate pressures on the GPs?
![Page 88: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/88.jpg)
General practice & pharmacyCommunication questionnaire
Vivek Patel
Charles Wharton
![Page 89: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/89.jpg)
![Page 90: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/90.jpg)
![Page 91: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/91.jpg)
So if we can't communicate in writing how well do we manage by other means?
![Page 92: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/92.jpg)
Audit of patient experiences and opinions on the communication between GP surgeries and pharmacies.
![Page 93: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/93.jpg)
What do patients think?
1. Do you think GP surgeries and pharmacies communicate with each other often?
0
1
2
3
4
5
6
7
8
9
1 2 3 4 5
23 patients
Nu
mb
er
of
resp
on
ses
Neverconstantly
![Page 94: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/94.jpg)
What do patients think?
2. How well do you think they achieve this?
23 patients
Nu
mb
er
of
resp
on
ses
Very poorexcellent
0
1
2
3
4
5
6
7
8
1 2 3 4 5
![Page 95: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/95.jpg)
Q3: Have you had any experiences of this, either positive or negative?
• positive 7
• negative 3
• mixed 1
• neither 11
“very happy, always warm welcome talking deep through the problem, overall very satisfied.”
“Getting my emergency inhalers within one day as I had run out.”
“Doctors not specifiying drugs on one prescription –mixing up tablets/capsules then having to pay
double.”
“Negative – never had prescription ready.”
![Page 96: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/96.jpg)
Q4: What could be done to make it better?
• ?helpful 2
• worthless 6
• Blank 14
"communicate more, follow up on prescriptions""More digital integration? Not sure what is available now."
"Communicate better""it's already good"
![Page 97: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/97.jpg)
So the patients didn't have the answers.....
• Staff audit:
• Doctors difficult to get hold of
• Pharmacies send too many repeats
• Generally good, a few scripts sent back over minor errors, messing patients around
![Page 98: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/98.jpg)
So the patients didn't have the answers.....
• Staff audit:
• Continue this educational exchange
• Understand each others’ limitations
• GPs to call back quicker
• Surgery to inform pharmacy if repeat Rx rejected
• Regular meetings
![Page 99: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/99.jpg)
Our answer:
A single integrated IT system visible to patients, surgeries and pharmacies, allowing ordering, prescribing and dispensing, trackable at each step, with a messaging facility.
![Page 100: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/100.jpg)
But in the mean time……..
…….there is always the phone
![Page 101: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/101.jpg)
Questions
![Page 102: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/102.jpg)
QUALITY IMPROVEMENT
AUDIT 2017
![Page 103: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/103.jpg)
Healthcare Professional Pressures
GP Surgery Pharmacy
Limited NHS funding;
NHS net expenditure has increased from
~£75.billion in 2005/06 to ~£117billion in
2015/16. Planned expenditure for 2016/17 is
~£120bn and ~£123bn for 2017/18.¹
Department of Health cut to funding;
£113 million reduction in funding in 2016/17.³
Increased demand of patients in primary care;
The NHS deals with over 1 million patients every
36 hours.²
High number of pharmacists
Expectation from public continuously increasing. Expectation from public continuously increasing.
Increase in patient life expectancy. Increase in patient life expectancy.
1) http://www.nhsconfed.org/resources/key-statistics-on-the-nhs
2) Department of Health, Chief Executive's report to the NHS: December 2005
3) https://psnc.org.uk/our-news/government-imposes-community-pharmacy-funding-reduction/
![Page 104: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/104.jpg)
•Administration aid in polypharmacy, elderly and others.
•Use Repeat Dispensing System
•Prescription request made by pharmacy staff 1 week before medication is
due.
•Changes can be made to dosette box;
•Create whole new 4-week dosette box.
•Record kept in pharmacy of when each
patient’s MDS was made, and when
they are due.
•Record made of when patient collected
![Page 105: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/105.jpg)
![Page 106: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/106.jpg)
•No communication between GP and pharmacy when prescription request
is rejected.
•Changes made to a dosette box are not always communicated to the
pharmacy – be it from the GP or hospital.
•Stock issues in the pharmacy are not always disclosed with the GP.
![Page 107: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/107.jpg)
When a prescription is requested through the surgery – takes between 24-48 hours to
be reviewed and prescribed
Request handed in to surgery a week before prescription is due – Monday, Wednesday
and Friday (reduce GP workload).
May be rejected;
Overdue medication review
Change in medication (may be post-discharge)
Recently prescribed
Communication at this stage can be improved.
Solution; Shared computer system showing rejected requests, or bulletin from surgery
staff outlining this and reasons why.
![Page 108: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/108.jpg)
![Page 109: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/109.jpg)
![Page 110: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/110.jpg)
Changes made to medication in secondary care are not communicated
efficiently in the community setting.
MDS patients have medication changes regularly – vital that this information is
given to the GP and pharmacy to produce safe and correct dosette boxes.
One dispensing error reported from pharmacy in the last 6 months, which could
have been prevented with an accurate discharge summary being presented at
this stage.
Solution; Joint network that can be accessed by primary and secondary
healthcare setting, making it routine practice for a discharge letter to be shared.
![Page 111: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/111.jpg)
•Changes made to the dosette box by a GP must be followed by informing
the pharmacy.
•Occasionally, this hasn’t happened, and pharmacy staff must follow this up
•Can be attributed to GP workload – may be worthwhile for pharmacy staff
to access SCR more regularly.
•Solution; Shared IT system outlining change to medication, or increasing
pharmacy access to SCR.
![Page 112: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/112.jpg)
Stock control can have a big impact on MDS.
When a medicine is deemed out-of-stock, must be resolved by either switching to similar
medicine (usually of same class) or finding stock from elsewhere.
GP staff mentioned that they are rarely aware of stock issues – therefore can delay
treatment.
Solution; communication is critical to prevent issues here – may be rectified by sending
a weekly ‘out-of-stock medication’ list, compiled by pharmacy staff, to the GP surgery.
Can incorporate protocol into the SOPs
of the pharmacy, where an appropriate
alternative medicine is recommended to
the prescriber whenever possible.
![Page 113: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/113.jpg)
Shared IT system – although both parties have the SCR available, a
shared emis structure might allow for much clearer, easier-to-follow
pathway of patient care. This will help: To follow changes to a patient’s medication (and dosette box).
To follow a prescription request (whether it has been rejected or not).
To inform GP’s of unavailable medication (can send ‘out-of-stock’ bulletin previously
mentioned).
To improve communication – rather than by ‘Dear Dr. Note’.
Increase pharmacy access to SCR to confirm medication changes
![Page 114: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/114.jpg)
![Page 115: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/115.jpg)
Synchronising electronic
repeat dispensing for patients
on monitored dosage system
Mery Ayele
![Page 116: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/116.jpg)
Electronic Repeat Dispensing
• Prescriber issues batch of EPS prescriptions in one go for
suitable patients with repeat medication, for up to 12
months.
• Pharmacy responsible for carrying out checks with patient
before dispensing each issue.
• Patient reviewed regularly by pharmacy and has flexibility
throughout the regime.
![Page 117: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/117.jpg)
Prescribing an eRD batch
When a prescriber issues an electronic prescription for repeat dispensing this will contain the following information:
total quantity per issue
the intended duration of each issue of the prescription
how many times the repeatable prescription can be issued before the patient/medication should be reviewed.
![Page 118: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/118.jpg)
our pharmacy
160 of our patients are on monitored dosage system (MDS);
this counts for around 4,000 medicines
The eRD prescription received for MDS patients are mostly 7
days script.
![Page 119: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/119.jpg)
Issues
eRD for monitored dosage system was not synchronised
Patients on more than one medication were issued separate eRD for
each medication. The number of batches were inconsistent.
I. The batches run out at different times.
II. Request for patients’ eRD were sent at different time. Which is time
consuming given the number of items that are dispensed just for MDS
patients.
Miscommunication where there is change on patient’s medications.
![Page 120: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/120.jpg)
Electronic Repeat Dispensing chain
![Page 121: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/121.jpg)
Solution
Explained the issue to people who are in charge of authorising electronic repeat dispensing , which included GPs, practice pharmacist and reception team.
Where patient is prescribed a new prescription the batches issued should match with the batches remining of the other medication
Where medication is stopped pharmacy should be informed directly to prevent the use already issued eRD batch .
Synchronise eRD prescription for patients with different number of batches to dispense.
![Page 122: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/122.jpg)
Medication changes
Options:
cancel ALL outstanding items on the Spine and replace with a new batch
cancel individual item(s)
‘bridge the gap’ with a one-off script – if other medications are running out next week generate a one-off script until ready to start a new eRD batch for all items.
Good practice to communicate with pharmacy about changes.
![Page 123: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/123.jpg)
Preparing repeats for eRD
Check the issue duration / interval is correct for each repeat template.
Synchronise all items to be issued in the same eRD batch.
Ensure the number of authorised issues and/or review dates match up.
Consider issuing items in separate batches – eg CD 4 or 5, or PRN items
(irregular issue duration).
![Page 124: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/124.jpg)
Benefits for the Pharmacy
Effective time management.
Reduction in managed repeat workload.
Increased efficiency.
Better organised when preparing patients’ MDS
Less chance for error as the is better communication when patient’s medicine has been changed.
![Page 125: QIA Presentations - HEE LaSE Pharmacy · 3 Dr Dimple Shah and ... 5 Shreena Patel 6 Dr Diana Davenport and Nada Imame 7 Dr Kara Sheehan and Dr Pratiksha Nirmal 8 Dr Charles Wharton](https://reader034.vdocuments.us/reader034/viewer/2022042405/5f1d1ff0de8106701e031244/html5/thumbnails/125.jpg)
Benefits for the GP practice
Reduction in workload in re-signing requested repeat prescriptions.
Reduction in the amount of requests/queries coming into the practice.
Cancellation at any point during the regime at item or at prescription level.
New medication can be added to the regime.
Reduction in medicines waste.